Research · refreshed nightly · July 28, 2026

Top Medical Device Companies (July 2026)

Device makers ranked by growth.

The best-scoring device maker is not a household name. ChemoMetec, a Danish company at a $1.8B cap, ranks first among the 16 top medical device companies here with an MGI of 66, ahead of Intuitive Surgical at 63 and a $163B cap, roughly ninety times its size.

Devices reward patience over spectacle. Growth rates here cluster in the low teens, and the median MGI of 51.5 reflects steady clinical adoption rather than viral curves. UFP Technologies is the outlier on pace, compounding 24% a year both headline and per share, and KORU Medical makes the list at just a $199M cap. Click any name for the full citation-backed analysis.

50companies qualify
58.5median MGI
11joined this week

The ranking

Sorted by MGI
1
Insulet CorporationPODD🇺🇸
Revenue +21%/yr · +21%/yr per share · asset light
G 72V 62O 78Cap $13.0B
2
Sectra ABSECT.B.SE🇸🇪
Revenue +15%/yr · +15%/yr per share · asset light
G 71V 52O 72Cap $4.9B
3
Kuros Biosciences LtdKURN.CH🇨🇭
Revenue +101%/yr · +80%/yr per share · asset light
G 70V 59O 74Cap $1.0B
4
AtriCure, Inc.ATRC🇺🇸
Revenue +16%/yr · +14%/yr per share · asset light
G 69V 59O 72Cap $1.7B
5
Bittium OyjBITTI.FI🇫🇮
Revenue +9%/yr · +9%/yr per share · asset light
G 68V 45O 67Cap $1.2B
6
ResMed Inc.RMD🇺🇸
Revenue +10%/yr · +10%/yr per share · asset light
G 67V 62O 75Cap $31.0B
7
Intuitive Surgical, Inc.ISRG🇺🇸
Revenue +14%/yr · +14%/yr per share · asset light
G 66V 51O 67Cap $134.3B
8
ChemoMetec A/SCHEMM.DK🇩🇰
Revenue +15%/yr · +15%/yr per share · asset light
G 66V 39O 63Cap $1.9B
9
Paxman ABPAX.GB🇬🇧
Revenue +27%/yr · +20%/yr per share · asset light
G 65V 62O 69Cap $128.5M
10
DexCom, Inc.DXCM🇺🇸
Revenue +14%/yr · +16%/yr per share · asset light
G 65V 63O 71Cap $26.3B
11
BrainsWay Ltd.BWAY🇮🇱
Revenue +14%/yr · +8%/yr per share · asset light
G 64V 57O 66Cap $584.2M
12
Stille ABSTIL.SE🇸🇪
Revenue +29%/yr · +15%/yr per share · scale economics
G 64V 61O 67Cap $206M
13
Penumbra, Inc.PEN🇺🇸
Revenue +14%/yr · +11%/yr per share · asset light
G 63V 54O 65Cap $12.7B
14
SI-BONE, Inc.SIBN🇺🇸
Revenue +18%/yr · +12%/yr per share · asset light
G 62V 68O 68Cap $657.2M
15
Medacta Group SAMOVE.CH🇨🇭
Revenue +18%/yr · +18%/yr per share · asset light
G 62V 49O 62Cap $3.4B
16
LeMaitre Vascular, Inc.LMAT🇺🇸
Revenue +11%/yr · +9%/yr per share · asset light
G 61V 54O 63Cap $2.4B
17
UFP Technologies, Inc.UFPT🇺🇸
Revenue +24%/yr · +24%/yr per share · scale economics
G 61V 56O 63Cap $1.7B
18
Electromed, Inc.ELMD🇺🇸
Revenue +13%/yr · +14%/yr per share · asset light
G 61V 61O 66Cap $330M
19
NIOX Group plcNIOX.GB🇬🇧
Revenue +15%/yr · +13%/yr per share · asset light
G 61V 60O 64Cap $364.8M
20
Tristel plcTSTL.GB🇬🇧
Revenue +9%/yr · +9%/yr per share · asset light
G 61V 60O 63Cap $263.7M
21
Glaukos CorporationGKOS🇺🇸
Revenue +13%/yr · +9%/yr per share · asset light
G 60V 50O 60Cap $8.9B
22
Viemed Healthcare, Inc.VMD🇺🇸
Revenue +20%/yr · +20%/yr per share · asset light
G 60V 68O 66Cap $409.8M
23
Boston Scientific CorporationBSX🇺🇸
Revenue +12%/yr · +11%/yr per share · asset light
G 59V 49O 59Cap $80.5B
24
TransMedics Group, Inc.TMDX🇺🇸
Revenue +84%/yr · +71%/yr per share · asset light
G 59V 64O 64Cap $3.0B
25
Delcath Systems, Inc.DCTH🇺🇸
Revenue +91%/yr · +37%/yr per share · asset light
G 59V 69O 65Cap $366M
26
CeriBell, Inc.CBLL🇺🇸
Revenue +28%/yr · -33%/yr per share · asset light
G 58V 69O 64Cap $690.9M
27
Straumann Holding AGSTMN.CH🇨🇭
Revenue +13%/yr · +13%/yr per share · asset light
G 58V 46O 56Cap $18.5B
28
Medistim ASAMEDI.NO🇳🇴
Revenue +11%/yr · +11%/yr per share · asset light
G 58V 59O 60Cap $450.1M
29
Prim, S.A.PRM.ES🇪🇸
Revenue +11%/yr · +12%/yr per share · asset light
G 58V 62O 61Cap $256.6M
30
Globus Medical, Inc.GMED🇺🇸
Revenue +26%/yr · +20%/yr per share · asset light
G 57V 55O 59Cap $11.2B
31
Ion Beam Applications SAIBAB.BE🇧🇪
Revenue +15%/yr · +14%/yr per share · scale economics
G 53V 65O 57Cap $511M
32
EssilorLuxottica S.A.EL.FR🇫🇷
Revenue +15%/yr · +13%/yr per share · asset light
G 53V 58O 57Cap $86.3B
33
Kromek Group plcKMK.GB🇬🇧
Revenue +25%/yr · +10%/yr per share · asset light
G 53V 66O 56Cap $64M
34
Asker Healthcare Group ABASKER.SE🇸🇪
Revenue +14%/yr · +3%/yr per share · scale economics
G 53V 56O 55Cap $3.2B
35
iRhythm Holdings, Inc.IRTC🇺🇸
Revenue +20%/yr · +17%/yr per share · asset light
G 51V 55O 53Cap $3.8B
36
Devyser Diagnostics ABDVYSR.SE🇸🇪
Revenue +22%/yr · +14%/yr per share · asset light
G 51V 53O 52Cap $167.3M
37
Inspire Medical Systems, Inc.INSP🇺🇸
Revenue +31%/yr · +30%/yr per share · asset light
G 50V 68O 55Cap $1.5B
38
Tactile Systems Technology, Inc.TCMD🇺🇸
Revenue +11%/yr · +7%/yr per share · asset light
G 50V 60O 53Cap $609.8M
39
Axogen, Inc.AXGN🇺🇸
Revenue +13%/yr · +10%/yr per share · asset light
G 49V 49O 49Cap $2.0B
40
LUMIBIRD SALBIRD.FR🇫🇷
Revenue +12%/yr · +8%/yr per share · asset light
G 48V 53O 49Cap $603.6M
41
Surgical Science Sweden ABSUS.SE🇸🇪
Revenue +22%/yr · +17%/yr per share · asset light
G 47V 74O 52Cap $161.3M
42
Pro-Dex, Inc.PDEX🇺🇸
Revenue +13%/yr · -62%/yr per share · scale economics
G 46V 53O 47Cap $169.9M
43
SCHOTT Pharma AG & Co. KGaA1SXP.DE🇩🇪
Revenue +74%/yr · +60%/yr per share · scale economics
G 46V 54O 47Cap $3.6B
44
Demant A/SDEMANT.DK🇩🇰
Revenue +10%/yr · +12%/yr per share · asset light
G 46V 62O 51Cap $7.0B
45
NeuroPace, Inc.NPCE🇺🇸
Revenue +17%/yr · +2%/yr per share · asset light
G 45V 63O 48Cap $483.8M
46
Profound Medical Corp.PRN.CA🇨🇦
Revenue +22%/yr · +12%/yr per share · asset light
G 44V 60O 46Cap $282.2M
47
RxSight, Inc.RXST🇺🇸
Revenue +41%/yr · +13%/yr per share · asset light
G 44V 61O 46Cap $244.2M
48
Cytek Biosciences, Inc.CTKB🇺🇸
Revenue +10%/yr · +0%/yr per share · asset light
G 44V 59O 46Cap $566.9M
49
Medartis Holding AGMED.CH🇨🇭
Revenue +16%/yr · +15%/yr per share · asset light
G 44V 44O 43Cap $1.3B
50
MiniMed Group, Inc.MMED🇺🇸
Revenue +11%/yr · +11%/yr per share · asset light
G 44V 61O 47Cap $4.3B

Changed this week

Week over week, from the nightly refresh.

Related research

Every ranking refreshes nightly from the same engine.

Want this list your way?
Run it as a live search: add size, geography or profitability in plain English, then ask Dig Deeper to reason over the results.
Run it as a search →

Research tool, not investment advice. Rankings are generated by our models from company filings and market data, refresh nightly, and are identical for every visitor. Scores reflect our methodology and are not recommendations to act. Data as of 2026-07-28.